CI
GSK icon

Cordant Inc’s GSK GSK Stock Holding History

Cordant Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$784 Buy
+15
New +$793 ﹤0.01% 167
2020
Q4 		– Sell
-72
Closed -$3K – 54
2020
Q3 		$3K Buy
+72
New +$3.61K ﹤0.01% 55

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Cordant Inc's GSK Position: Q2 2026 in Review

Cordant Inc opened a new position in GSK (GSK) in Q2 2026: 15 shares worth $784. The stake represents ﹤0.01% of the portfolio and ranks #167 among its holdings. This is a return to the name: Cordant Inc previously reported a position in GSK as recently as Q3 2020.

Cordant Inc first reported a position in GSK in Q3 2020 and has held it in 2 quarters since. The position peaked at $3K in Q3 2020. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Cordant Inc held 15 shares of GSK worth $784 as of Q2 2026.
  • GSK was a new Cordant Inc position in Q2 2026.
  • GSK made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #167 holding.
  • Cordant Inc first reported a position in GSK in Q3 2020 and has held it in 2 quarters since.
  • Cordant Inc's GSK position peaked at $3K in Q3 2020.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.